Meeting
2016 ASCO Annual Meeting
Genomic complexity in KRAS mutant non-small cell lung cancer (NSCLC) from never/light-smokers v smokers.
Authors
Amanda J. Redig
Dana-Farber Cancer Institute, Boston, MA
Amanda J. Redig , Emily S. Chambers , Christine A. Lydon , Suzanne Eleanor Dahlberg , Ryan S. Alden , Pasi A. Janne
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 9087)
DOI
10.1200/JCO.2016.34.15_suppl.9087
Abstract #
9087
Poster Bd #
410
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
ECOG-ACRIN LUNG-MAP S1900E substudy: A phase II study of sotorasib in participants (Pts) with previously treated stage IV or recurrent KRAS G12C mutant non-squamous (Non-sq) non-small cell lung cancer (NSCLC).
First Author: Sukhmani Kaur Padda
Poster
2022 ASCO Annual Meeting
The distribution of genetic mutations correlated with resistance to KRASG12C inhibitors in Chinese patients with lung cancer.
First Author: Shengcheng Lin
Poster
2021 ASCO Annual Meeting
Clinicogenomic real-world data analysis of patients (pts) with KRAS G12C-mutant advanced non-small cell lung cancer (aNSCLC) from the natural history cohort of the Blood First Assay Screening Trial (BFAST).
First Author: Rafal Dziadziuszko
Poster
2017 ASCO Annual Meeting
KRAS in non-small cell lung cancer: Single institution experience—What factors are involved?
First Author: Idoroenyi Usua Amanam